Oregon Health and Science University (OHSU) and RevMedx Inc. won a USAID/Gates-sponsored seed grant to develop a novel treatment for postpartum hemorrhage based on RevMedx’s XSTAT™ technology. The OHSU/RevMedx proposal was selected from more than 400 submissions in the Saving Lives at Birth Grand Challenge—an international effort to dramatically reduce maternal and neonatal deaths.